2003
DOI: 10.1016/j.bbrc.2003.10.165
|View full text |Cite
|
Sign up to set email alerts
|

TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 32 publications
1
9
0
Order By: Relevance
“…Conversely, yeast lacking the catalytic subunit Cka1 were approximately as resistant as wild type cells (Figure 4C). These results suggest that the activity of the holoenzyme and not only of the free catalytic subunits, which are known to have functions independent of the regulatory subunits [57], are responsible for the phenotypes observed. Furthermore, the involvement of both Ckb1 and Ckb2 in the regulation of stress resistance is in agreement with the requirement of both regulatory subunits for the full CK2 activation [56].…”
Section: Resultsmentioning
confidence: 81%
See 2 more Smart Citations
“…Conversely, yeast lacking the catalytic subunit Cka1 were approximately as resistant as wild type cells (Figure 4C). These results suggest that the activity of the holoenzyme and not only of the free catalytic subunits, which are known to have functions independent of the regulatory subunits [57], are responsible for the phenotypes observed. Furthermore, the involvement of both Ckb1 and Ckb2 in the regulation of stress resistance is in agreement with the requirement of both regulatory subunits for the full CK2 activation [56].…”
Section: Resultsmentioning
confidence: 81%
“…Lack of Ckb2 promoted a modest but significant (p<0.05) longevity extension and a marked increase of heat resistance in comparison with the wild type (Figure 5B, Figure 6B). Two highly specific CK2 inhibitors, 4,5,6,7-tetrabromo-benzotriazole (TBBt) and 4,5,6,7-tetrabromo-benzimidazole (TBBz), have been identified and shown to inhibit the activity of the holoenzyme [57]. More specifically, in yeast TBBz inhibits the CK2 complex selectively and not the free Cka2 catalytic subunits [57].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…TBBz has been shown to inhibit specifically the CkII holoenzyme by ATP competition with effective concentrations in yeast of 10-200 µm (Fabrizio et al, 2010; Zień et al, 2003). We observed that pharmacological inhibition of CkII, using 200 µm TBBz, in flies overexpressing slgA-D or -E in the LNv, leads to hyperaggression compared with control flies (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…To this end, we investigated the effects of CK2 inhibitors on p53 and HIF-1␣ protein level and activity. Apigenin (Ford et Zhu et al, 2002), DRB (5,6-Dichloro-1-␤-Dribofuranosyl-benzimidazole) (Blaydes and Hupp, 1998;Critchfield et al, 1997;Farah et al, 2003) and TBB (3,4,5,6-tetrabromo-triazole) (Ruzzene et al, 2002;Zien et al, 2003) were used as CK2-specific inhibitors. An inverse relationship was observed with decreased HIF-1 activity in parallel with increased p53 protein level and activity in the presence of these inhibitors.…”
Section: Introductionmentioning
confidence: 99%